Veradermics, Incorporated (MANE)
Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions.
$106.37+0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+176.4%
The outlook
Veradermics, Incorporated currently reads as bullish based on strong buy — 1.1 avg of 6 analysts, mixed vs its moving averages, 75% of the way from its 52-week low to high, avg target +54% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.1 avg of 6 analysts
Price trendMixed vs its moving averages
52-week range75% of the way from its 52-week low to high
Price targetAvg target +54% vs current price
Analyst price target
~12-month · 6 analysts$163.50average target+53.7% vs now
Now $106.37
Low $135.00High $182.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$4.44B
52-wk high
$131.24
52-wk low
$32.00
50-day avg
$107.47
200-day avg
$83.46
Trailing P/E
—